Abstract

Advancements in neonatal screening have significantly transformed pediatric care by enabling the early detection and intervention of a wide range of congenital and metabolic disorders. These advancements have led to improved health outcomes, reduced mortality, and the prevention of long-term developmental disabilities in newborns. Technological innovations, such as expanded screening panels, genetic testing, and enhanced biomarkers, have expanded the scope of conditions that can be detected in the neonatal period. Additionally, improvements in data integration and follow-up care systems have ensured that timely interventions are provided. This paper explores the latest developments in neonatal screening, their impact on pediatric healthcare, and the ongoing challenges of implementation in diverse healthcare settings. It underscores the critical role of neonatal screening in shaping a healthier future for children by emphasizing the importance of early diagnosis and individualized care.